Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Completed

Conditions studied: Multiple Myeloma, Myeloma, Multiple, Myeloma-Multiple

In brief

This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus vaccines. The main goal of the study is to start to identify differences in the immune response between multiple myeloma patients and people who don't have multiple myeloma. We hope this will provide important information about the best way and time to vaccinate multiple myeloma patients to flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus .

Key facts

Study ID

NCT02294487

Run by

Wake Forest University Health Sciences

People needed

19

Starts

2014-12-30

Expected to finish

2017-08-10

Last updated by the study team

2024-10-03

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 50 years old or over
• planning on getting the seasonal flu and/or pneumonia vaccine as part of normal care
• have multiple myeloma, or don't have multiple myeloma and want to serve as a health control

You may not qualify if…

• do not meet inclusion criteria

Where it is running

• Aurora Health Care — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.